N. Christiansen

Safety of bevacizumab (BV) among patients (pts) receiving first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): Preliminary results from a larger registry in the U.S

R. Robles, A. Grothey, F. Kabbinavar, 2005 .

Pemetrexed plus gemcitabine as front-line therapy for patients with advanced stage non-small cell lung cancer.

C. Obasaju, D. Mintzer, P. Bonomi, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation

M. Wetzler, M. Baer, J. Schriber, 1999, Bone Marrow Transplantation.

Epstein–Barr virus-associated B cell lymphoproliferative disorder following mismatched related T cell-depleted bone marrow transplantation

P. Henslee-Downey, F. Rhee, K. Godder, 2001, Bone Marrow Transplantation.

Allogeneic bone marrow transplantation for the treatment of adult acute leukemias.

N. Christiansen, 1993, Hematology/oncology clinics of North America.

CD34 progenitor cell subset analyses in normal human bone marrow and marrow harvested after intermediate-dose chemotherapy.

L. Blumenson, C. Stewart, D. Bonney, 1996, Cytometry.

A multicenter, phase II study of CPX-1 liposome injection in patients (pts) with advanced colorectal cancer (CRC)

G. Batist, D. Spigel, N. Gabrail, 2008 .

Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.

M. Caligiuri, C. Bloomfield, S. Knuutila, 1996, Blood.